The Management Story of SCL: Pioneering the Era of Accurate laboratory medicine

When visiting the hospital to diagnose an illness, patients undergo a routine process: clinical specimens like blood are collected and sent to a testing agency. Only after the test results are received can doctors precisely diagnose the disease and determine the subsequent treatment. These laboratory medicine, often conducted out of the public eye, play a crucial and intimate role in our healthcare system. The recent coronavirus pandemic has heightened public awareness and understanding of laboratory medicine, such as PCR and rapid antigen tests, with many people even using self-diagnosis kits at home.

This book traces its origins back 40 years, to a time when laboratory medicine was not as recognized and doctors’ experience was often the primary basis for treatment. It was during this period that ‘evidence-based medicine’ which insists that treatment should be supported by accurate evidence was introduced in Korea. Seoul Clinical Laboratories (SCL) was a pioneer during the early days of evidence-based medicine. Daring Different narrates the unseen efforts and achievements of SCL, which has been advancing Korea’s laboratory medicine field for four decades.

WHAT DOES SCL DO?
At the height of the coronavirus pandemic, laboratory medicine facilities like SCL were on the front lines of the battle against the virus. Before the pandemic, SCL conducted approximately 500 tests per day; during the pandemic, this number soared to 3,000 to 4,000. Employees took up residence near the company to manage the relentless stream of specimens for coronavirus testing. With the expectation that new viruses will continue to emerge, interest in medical companies like SCL is surging.
Reflecting on the journey that Seoul Clinical Laboratories (SCL) has charted in this book, you will discover many significant events that have occurred in our country. This is because SCL represents a living history in the field of laboratory medicine. One notable example is the mitochondrial nucleic acid analysis of victims affected by humidifier disinfectants. Given the high-profile nature of this case, it was inevitable that SCL felt a tremendous burden. Nevertheless, the testing agency maintained a steadfast commitment to delivering results based solely on scientific facts, despite external pressures. The fact that SCL was chosen to conduct these tests and confirm mitochondrial genetic mutations in the victims highlights the crucial social role that medical professionals and laboratory medicine companies play.

Even now, there are individuals deeply engaged in the analysis of specimens within laboratory walls. Through the SCL employees featured in this book, readers can gain insight into their professional dedication and the challenges that they have experienced. These professionals adhere strictly to scientific accuracy and never compromise their integrity. They are also acutely aware that they have to see the human element behind each specimen. Although they typically remain unseen, their work is indispensable, acting as a vital component of the medical field. This is why this book resonates so profoundly, providing a tangible sense of reality and touching readers with its portrayal of business management in a critical sector.

SCL Takes up the Challenge to Become a Global Medical Leader

This book chronicles the journey of the medical company SCL from its humble beginnings in the laboratory medicine field to its rapid ascension to global leadership. Readers will discover the remarkable progress made over the past 40 years from the days when salespeople manually transported samples on express buses to the present era of sophisticated automated systems. The book details SCL’s challenges and triumphs in achieving the highest global standards and shares its philosophy and vision for managing a world-class medical company. The success story of SCL, defined by its unique specialties and clear strengths, will serve as a valuable reference for anyone interested in the medical industry. Additionally, case studies of various companies worldwide provide broader insights to readers.

SCL has not only pioneered advanced laboratory medicine methods but is also making significant strides in international markets. After expanding into Mongolia and China, the company is now spearheading the K-medical wave in Indonesia. The coronavirus pandemic underscored SCL’s exceptional level of medical diagnostic care globally. This book invites readers to explore the past, present, and future of our medical industry through SCL’s corporate narrative, illustrating how the values of ‘human-centric’ care and ‘growth’ as a company are being realized in tandem.